Herbert B. Newton Dr. Newton is currently the Director of the Neuro-Oncology Center and Brain Tumor Institute at the University Hospitals of Cleveland Medical Center and Seidman Cancer Center. He holds the William B. Risman Endowed Chair for Memory and Cognition. He retired as a Professor of neurology and neurosurgery at the Ohio State University Medical Center and the James Cancer Hospital, and was the holder of the Esther Dardinger Endowed Chair in Neuro-Oncology. He trained in neuro-oncology with Drs. Jerome Posner and William Shapiro at Memorial Sloan Kettering Cancer Center in New York and has been in academic neuro-oncology for over 30 years. He has published more than 230 peer-reviewed articles and book chapters and is the Chief Editor or Co-Editor of 13 textbooks in the field of neurology and neuro-oncology. In addition, he has been listed as a Best Doctor (neurology) and Top Doctor for cancer (neuro-oncology) for the past 23 years .

• Section 1: PHARMACOLOGICAL AND CLINICAL APPLICATIONSSection 2: INNOVATIVE CHEMOTHERAPY DELIVERYSection 3: MOLECULAR BIOLOGY AND MOLECULAR THERAPEUTICSSection 4: CHEMOTHERAPY SPECIFIC TUMORS – ADULTSSection 5: CHEMOTHERAPY SPECIFIC TUMORS – PEDIATRICSSection 6: IMMUNOTHERAPY FOR BRAIN TUMORSSection 7: RESPONSE ASSESSMENT, QUALITY OF LIFE, NEUROPSYCHOLOGY, AND NEW FRONTIERS

Herbert B. Newton Dr. Newton is currently the Director of the Neuro-Oncology Center and Brain Tumor Institute at the University Hospitals of Cleveland Medical Center and Seidman Cancer Center. He holds the William B. Risman Endowed Chair for Memory and Cognition. He retired as a Professor of neurology and neurosurgery at the Ohio State University Medical Center and the James Cancer Hospital, and was the holder of the Esther Dardinger Endowed Chair in Neuro-Oncology. He trained in neuro-oncology with Drs. Jerome Posner and William Shapiro at Memorial Sloan Kettering Cancer Center in New York and has been in academic neuro-oncology for over 30 years. He has published more than 230 peer-reviewed articles and book chapters and is the Chief Editor or Co-Editor of 13 textbooks in the field of neurology and neuro-oncology. In addition, he has been listed as a Best Doctor (neurology) and Top Doctor for cancer (neuro-oncology) for the past 23 years .

• Section 1: PHARMACOLOGICAL AND CLINICAL APPLICATIONSSection 2: INNOVATIVE CHEMOTHERAPY DELIVERYSection 3: MOLECULAR BIOLOGY AND MOLECULAR THERAPEUTICSSection 4: CHEMOTHERAPY SPECIFIC TUMORS – ADULTSSection 5: CHEMOTHERAPY SPECIFIC TUMORS – PEDIATRICSSection 6: IMMUNOTHERAPY FOR BRAIN TUMORSSection 7: RESPONSE ASSESSMENT, QUALITY OF LIFE, NEUROPSYCHOLOGY, AND NEW FRONTIERS

Herbert B. Newton Dr. Newton is currently the Director of the Neuro-Oncology Center and Brain Tumor Institute at the University Hospitals of Cleveland Medical Center and Seidman Cancer Center. He holds the William B. Risman Endowed Chair for Memory and Cognition. He retired as a Professor of neurology and neurosurgery at the Ohio State University Medical Center and the James Cancer Hospital, and was the holder of the Esther Dardinger Endowed Chair in Neuro-Oncology. He trained in neuro-oncology with Drs. Jerome Posner and William Shapiro at Memorial Sloan Kettering Cancer Center in New York and has been in academic neuro-oncology for over 30 years. He has published more than 230 peer-reviewed articles and book chapters and is the Chief Editor or Co-Editor of 13 textbooks in the field of neurology and neuro-oncology. In addition, he has been listed as a Best Doctor (neurology) and Top Doctor for cancer (neuro-oncology) for the past 23 years .

• Section 1: PHARMACOLOGICAL AND CLINICAL APPLICATIONSSection 2: INNOVATIVE CHEMOTHERAPY DELIVERYSection 3: MOLECULAR BIOLOGY AND MOLECULAR THERAPEUTICSSection 4: CHEMOTHERAPY SPECIFIC TUMORS – ADULTSSection 5: CHEMOTHERAPY SPECIFIC TUMORS – PEDIATRICSSection 6: IMMUNOTHERAPY FOR BRAIN TUMORSSection 7: RESPONSE ASSESSMENT, QUALITY OF LIFE, NEUROPSYCHOLOGY, AND NEW FRONTIERS